Skip to main content
Premium Trial:

Request an Annual Quote

NJ's Reproductive Medicine Associates Licenses GeneGo's MetaCore

NEW YORK (GenomeWeb News) - GeneGo today said it has licensed its MetaCore technology to the Reproductive Medicine Associates of New Jersey.
The facility will use the tool to analyze gene-expression data in research and in their clinic. Julie Bryant, vice president of business development at GeneGo, said this is the first time MetaCore will be used by health-care practitioners instead of pharmaceutical companies or academic groups.
Financial details for the multi-year agreement were not disclosed.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.